153 related articles for article (PubMed ID: 17513310)
21. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
22. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
24. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
25. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.
Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K
Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175
[TBL] [Abstract][Full Text] [Related]
26. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
27. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
[TBL] [Abstract][Full Text] [Related]
28. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
29. Novel Hyaluronan Formulation Enhances the Efficacy of Boron Neutron Capture Therapy for Murine Mesothelioma.
Sasai M; Nakamura H; Sougawa N; Sakurai Y; Suzuki M; Lee CM
Anticancer Res; 2016 Mar; 36(3):907-11. PubMed ID: 26976977
[TBL] [Abstract][Full Text] [Related]
30. Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy.
Fujita Y; Yamamoto N; Kato I; Iwai S; Ono K; Sakurai Y; Ohnishi K; Ohnishi T; Yura Y
Int J Radiat Biol; 2011 Mar; 87(3):293-301. PubMed ID: 21142704
[TBL] [Abstract][Full Text] [Related]
31. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
32. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.
Ariyoshi Y; Miyatake S; Kimura Y; Shimahara T; Kawabata S; Nagata K; Suzuki M; Maruhashi A; Ono K; Shimahara M
Oncol Rep; 2007 Oct; 18(4):861-6. PubMed ID: 17786347
[TBL] [Abstract][Full Text] [Related]
33. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells.
Kamida A; Fujita Y; Kato I; Iwai S; Ono K; Suzuki M; Sakurai Y; Yura Y
Int J Radiat Biol; 2008 Mar; 84(3):191-9. PubMed ID: 18300019
[TBL] [Abstract][Full Text] [Related]
34. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
35. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
36. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
37. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
38. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
[TBL] [Abstract][Full Text] [Related]
39. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]